80 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We … , there is also no assurance that we will have timely knowledge of our status as a PFIC in the future or of the required information to be provided
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
) The Company and each of its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that (i … an opinion and negative assurance letter of Goodwin Procter LLP, outside counsel for the Company, dated the Closing Date, in form and substance
8-K
EX-99.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed
424B5
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Prospectus supplement for primary offering
4:40pm
for use in connection with this offering. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any … no assurance that we will have timely knowledge of our status as a PFIC in the future or of the required information to be provided.
U.S. Holders can avoid
8-K
EX-99.2
CNTA
Centessa Pharmaceuticals plc
10 Sep 24
Regulation FD Disclosure
7:08am
or licensing within such jurisdiction. any indication, assurance or guarantee that the assumptions on which such forward looking statements have been
DEFA14A
cso63q9yocbx4yr9 m2
20 May 24
Additional proxy soliciting materials
8:48pm
424B5
t37sg98y3zcmn2b5yf
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
EX-99.1
zugm vrzg5vu
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
8-K
EX-1.1
8rq73ugfsfnrp 24
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
cwq8m2m4pqfok
23 Apr 24
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.2
g5vm1i09
22 Apr 24
Regulation FD Disclosure
7:15am